Albany, NY -- (SBWIRE) -- 08/30/2016 -- The global market for ocular drug delivery technologies is examined in a recent market research report by Transparency Market Research. The report, titled "Ocular Drug Delivery Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020," presents a thorough overview of the chief factors surmised to have a notable impact on the development of the market in the near future.

The vast rise in world's geriatric population, increased investments towards research and development of sustained drug release technologies, increased prevalence of lifestyle diseases, and increased initiatives undertaken by government bodies towards the development of healthcare facilities, especially across developing economies are the key drivers of the market. Owing to the fact that conventional ocular drug delivery modalities such as eye drops and ocular ointments suffer the inherent drawback of poor bioavailability, usually ranging from 1-10% of the administered volume of the drug, many ophthalmic drugs are used in high concentrations. As this practice can lead to several unwanted ocular and systemic reactions, the demand for sustained release devices that can provide alternative drug delivery routes for eyes has been rising over the past few years.

The vast research and development activities aimed at enabling the development of such ocular drug delivery modes have led to the introduction or inception of several promising technologies such as ocular inserts, collagen shields, and biodegradable polymeric systems in the global market lately. Ocular inserts enable a substantial rise in the contact time between the ocular drug and the conjunctival tissue, ensuring sustained release of drugs suitable for systemic or topical treatment. In the near future, such advanced ocular drug release mechanisms are expected to hold a commanding position in the global ocular drug delivery technologies market.

The report examines the variety of ocular drug delivery technologies presently available in the market, along with the ones that are presently in their developmental stages. The report also examines the markets for ocular drug delivery technologies for key regional markets such as Asia Pacific, North America, Europe, and the Rest of the World.

A detailed overview of the competitive landscape is also included in the report, with thorough business profiles of some of the most prominent vendors in the market. An analysis of major breakthroughs in terms of product innovations and approvals, activities such as mergers and acquisitions, and changes in the regulatory framework of key regional markets is also included in the report.

Some of the key companies operating in the market are Abbott Medical Optics, Hoya Corporation, CooperVision, Inc., and Bausch & Lomb, Inc.